b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30293926</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>21</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>21</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1995-9133</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>52</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Oct</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</Title>\n                <ISOAbbreviation>J Microbiol Immunol Infect</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>693-699</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1684-1182(18)30219-6</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmii.2018.08.017</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND/PURPOSE" NlmCategory="OBJECTIVE">HIV-infected patients have a high prevalence of low bone mineral density (BMD), but BMD changes remain unclear. This cross-sectional retrospective observational study aimed to characterize the prevalence and associated factors of low BMD in HIV patients.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">Between 1 January 2015 and 31 December 2016, all patients aged 20 years or greater who sought for HIV care were included. BMD was measured by dual-energy X-ray absorptiometry. Multivariable analyses of the association with HIV disease status, treatment and anthropometric parameters were performed. Circulating fibroblast growth factor 23 and intact parathyroid hormone were measured.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 137 patients was included; their median age was 39 years old; 97.8% were treated with combination antiretroviral therapy (cART); Body mass index (BMI) was 21.97\xc2\xa0kg/m<sup>2</sup>. Sixty-one patients (44.5%) showed low BMD (osteopenia and osteoporosis) based on the WHO criteria. The median BMD was -0.80\xc2\xa0g/cm<sup>2</sup> (IQR, -1.5 to -0.2). The prevalence rate of low BMD was 37% in those who were aged 20-29 years, 45.2% in those who were aged 30-39 years, 45.2% in those who were aged 40-49 years, 45.8% in those who were aged 50-59 years, and 53.8% in those who were aged \xe2\x89\xa760 years. More than half of patients (50.4%, 69/137) were younger than 40 years. Compared with normal BMD group, the low BMD group has a higher proportion of secondary hyperparathyroidism (18.0% vs 5.3%, p: 0.026) and a lower median C-terminal FGF23 level (48.92 vs 62.61\xc2\xa0pg/ml, p: 0.008). Univariate and multivariate analyses of the factors associated with low BMD. We found that only serum intact-parathyroid hormone (iPTH)\xc2\xa0&gt;\xc2\xa069\xc2\xa0pg/ml (OR, 3.86; 95% CI, 1.14-13.09) was statistically significant associated with low BMD in multivariate analysis.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This cohort-based survey showed a high prevalence of low BMD among HIV-infected adults which included young-age patient in an university hospital. Secondary hyperparathyroidism was significantly associated with low BMD. There was no association between FGF23 and low BMD.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018. Published by Elsevier B.V.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Chen</LastName>\n                    <ForeName>Kuan-Yu</ForeName>\n                    <Initials>KY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Ching-Hsun</ForeName>\n                    <Initials>CH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lin</LastName>\n                    <ForeName>Te-Yu</ForeName>\n                    <Initials>TY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chang</LastName>\n                    <ForeName>Chan-Yuan</ForeName>\n                    <Initials>CY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Liu</LastName>\n                    <ForeName>Chang-Lin</ForeName>\n                    <Initials>CL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hsiao</LastName>\n                    <ForeName>Yu-Chun</ForeName>\n                    <Initials>YC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hung</LastName>\n                    <ForeName>Ching-Ching</ForeName>\n                    <Initials>CC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Ning-Chi</ForeName>\n                    <Initials>NC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address: wangmax49@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>22</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Microbiol Immunol Infect</MedlineTA>\n            <NlmUniqueID>100956211</NlmUniqueID>\n            <ISSNLinking>1684-1182</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>62031-54-3</RegistryNumber>\n                <NameOfSubstance UI="D005346">Fibroblast Growth Factors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>7Q7P4S7RRE</RegistryNumber>\n                <NameOfSubstance UI="C416507">fibroblast growth factor 23</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001851" MajorTopicYN="N">Bone Diseases, Metabolic</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005346" MajorTopicYN="N">Fibroblast Growth Factors</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006961" MajorTopicYN="N">Hyperparathyroidism</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010361" MajorTopicYN="N">Patients</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Fibroblast growth factor 23</Keyword>\n            <Keyword MajorTopicYN="N">HIV</Keyword>\n            <Keyword MajorTopicYN="N">Hyperparathyroidism</Keyword>\n            <Keyword MajorTopicYN="N">Low bone mineral density</Keyword>\n            <Keyword MajorTopicYN="N">Osteopenia</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>9</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>9</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30293926</ArticleId>\n            <ArticleId IdType="pii">S1684-1182(18)30219-6</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jmii.2018.08.017</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'